Lamprene 50mg-SWI (Clofazimine Capsule) 50mg

Lamprene 50mg capsules contain clofazimine, a medication used primarily for treating leprosy and certain skin conditions. This antibiotic works by slowing bacterial growth. Store at room temperature and keep away from moisture. Always follow healthcare provider guidance when using.

Strength

50mg

Pack Size

100s

Storage

Ambient

Manufacturer / TM Owner

Novartis AG Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lamprene 50mg capsules are primarily used to treat leprosy, a bacterial infection affecting the skin and nerves. It may also be prescribed for other skin conditions like erythema nodosum leprosum (ENL), a painful skin reaction linked to leprosy treatment. This medication helps reduce inflammation and manage symptoms effectively.

Side Effects

Lamprene capsules may cause skin discoloration, turning the skin reddish-brown or even black. This change is temporary and usually fades after stopping the medication. Some users report mild stomach upset or dry skin while taking this drug.

Precautions & Warnings

Keep Lamprene 50mg capsules in a cool, dry place away from direct sunlight. Avoid crushing or opening capsules to prevent skin or eye contact with the powder. Inform your healthcare provider about any existing eye or liver conditions before use. Regular check-ups may be recommended during treatment.

Avoid Interactions

Lamprene may interact with medications that affect liver enzymes, such as certain antibiotics or antifungals. Combining it with vitamin A supplements could increase the risk of side effects. Alcohol use may worsen stomach irritation. Always disclose all medications to your healthcare provider.

Frequently Asked Questions

Clofazimine is primarily used to treat leprosy and manage skin reactions like erythema nodosum leprosum.

Yes, skin discoloration is a common effect that may occur during treatment.

Store at room temperature in a dry place, away from moisture and direct light.

Consult your healthcare provider before combining with other drugs to avoid interactions.

No, Lamprene requires a prescription from a licensed healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.